Akonni Wins $435K SBIR Grant to Develop POC Tuberculosis Dx on PCR Array Technology | GenomeWeb

By Ben Butkus

Akonni Biosystems said this week that it has been awarded a $435,000 grant from the National Institutes of Health to begin developing point-of-care diagnostics for drug-resistant tuberculosis strains based on the company's gel-drop PCR microarray biochip technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.